Thunen Shelley B 4
4 · RxSight, Inc. · Filed Jul 16, 2024
Insider Transaction Report
Form 4
RxSight, Inc.RXST
Thunen Shelley B
See remarks
Transactions
- Exercise/Conversion
Common Stock
2024-07-15$4.34/sh+16,505$71,632→ 30,443 total - Exercise/Conversion
Stock Option (right to buy)
2024-07-15−11,235→ 6,405 totalExercise: $4.34From: 2020-10-27Exp: 2026-10-26→ Common Stock (11,235 underlying) - Exercise/Conversion
Stock Option (right to buy)
2024-07-15−5,270→ 1,387 totalExercise: $4.34From: 2021-02-24Exp: 2027-03-13→ Common Stock (5,270 underlying)
Footnotes (1)
- [F1]Shares issued pursuant to the Issuer's 2015 Equity Incentive Plan, as amended.